InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,038.95
(
0.33%
)
US TECH 100
17,073.60
(
0.23%
)
Dow Jones
37,936.62
(
0.49%
)
Brent Oil
86.57
(
-0.48%
)
Bitcoin
63,417.71
(
3.48%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 363

Saturday, 09/22/2018 8:45:57 PM

Saturday, September 22, 2018 8:45:57 PM

Post# of 438
LPTX is focused on translational-stage molecules in cell signalling and immune oncology

The lead drug is an antibody in two Ph2 studies:
1) Esophageal and Biliary Tract Cancer in combo with Tence3ntriq
2) Monotherapy in Endometrial Cancer

The lead drug is also being studied in several Ph1 studies.

It's other clinical stage drug is an Immune Checkpoint Agonist in a
combo study with Keytruda.

The operational runway extends into Q2/20.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up